475 Targeting the JAK/STAT3 pathway with ruxolitinib for...

The Journal of Investigative Dermatology 2019 / 09 Vol. 139; Iss. 9

475 Targeting the JAK/STAT3 pathway with ruxolitinib for RDEB-cSCC therapy

Jackow, J., Hayashi, R., Owens, D., Perez-Lorenzo, R., Hansen, C., DeLorenzo, D., Guo, Z., Christiano, A.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
139
Language:
english
Journal:
Journal of Investigative Dermatology
DOI:
10.1016/j.jid.2019.07.525
Date:
September, 2019
File:
PDF, 191 KB
english, 2019
Conversion to is in progress
Conversion to is failed